1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Standard protocol for brain tumor imaging based on expert panel discussion following the framework of the ACRIN 6686 component of the RTOG 0825 protocol73
Standardized MR imaging protocol 3-Plane localizer/scout (in order of acquisition) T1-weighted precontrast (spin-echo) T2-weighted axial FLAIR (optional to perform after contrast) T1 map (quantitation) for DCE MR imaging—3D gradient-echo T1 or 2D TSE/FSE T1a DWI and/or DTI (can extract DWI data trace/ADC from DTI)a T2* DSC MR imaging (after presaturation DCE MR imaging sequence)a T1-weighted postcontrast (spin-echo) Functional language, auditory, visual, motor testing, and MRSa Can do FLAIR before DSC MR imaging SWI, gradient-echo, additional optional sequencesa General parameter recommendations Section thickness not greater than 5 mm Delay is recommended, which can be built in by performing DWI and/or DTI before acquiring T1 sequences. Another option is to perform FLAIR (or even T2) before T1 sequences, which may give additional sensitivity for leptomeningeal disease74 Target duration ≤30 minutes (maximum, 1.5–2.0 hr)
Note:—ACRIN indicates American College of Radiology Imaging Network; SWI, susceptibility-weighted imaging; RTOG = Radiation Therapy Oncology Group.
↵a Part of the ACRIN 6686 protocol but can be used as an adjunct in the clinical brain tumor protocol.